Addressing Financial Hardship in Adolescent and Young Adult Cancer Survivors
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Mar 17, 2025
Trial Information
Current as of April 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping young cancer survivors who are facing financial difficulties after their treatment. The study, called FinFit, aims to create and improve a program that supports these survivors, making it easier for them to manage any financial challenges they may encounter. The research is currently recruiting participants, specifically adults aged 18 and older who have experience with related programs and are familiar with the proposed support methods.
To take part in this trial, individuals need to have been involved in previous programs related to cancer support and the proposed FinFit initiative. Participants can expect to share their thoughts and experiences in interviews, which will help the researchers refine the support program. This trial is important because it seeks to address a critical issue that many young cancer survivors face, ensuring they receive the help they need to thrive after their treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Adults (ages 18 years of age or older) with perspectives on CHAT, LIFT, FinFit's proposed forms, and those from any community-based practices that were originally part of CHAT or LIFT administration are eligible for inclusion in Aim 1 interviews.
- Exclusion Criteria:
- • - Those not involved in any of the preliminary programs, not familiar with the proposed forms of FinFit, or not involved in the proposed implementation sites will not be eligible for participation.
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
John Salsman, PhD
Principal Investigator
Wake Forest Baptist Comprehensive Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported